Introduction
Hepatitis C virus (HCV) is a major cause of hepatitis worldwide. The majority of HCV infected individuals develop chronic hepatitis that may progress to liver cirrhosis and hepatocellular carcinoma. Treatment options for chronic HCV infection are limited and a vaccine to prevent HCV infection is not available. HCV has been classified in a separate genus (Hepacivirus) of the Flaviviridae family. The virion contains a positive-stranded RNA genome of approximately 9.6 kb that is translated into a single polyprotein of about 3,000 amino acids. Processing
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Core protein ؒ Hepatitis C virus ؒ Toll-like receptors Abstract Toll-like receptors (TLRs) are pathogen recognition molecules activating the innate immune system. Cell surface expressed TLRs, such as TLR2 and TLR4, have been shown to play an important role in human host defenses against viruses through sensing of viral structural proteins. In this study, we aimed to elucidate whether TLR2 and TLR4 participate in inducing antiviral immunity against hepatitis C virus (HCV) by sensing viral structural proteins. We studied TLR2 and TLR4 activation by cell culture-derived infectious virions and serum-derived virions in comparison to purified recombinant HCV structural proteins and enveloped viruslike particles. Incubation of TLR2 or TLR4 transfected cell lines with recombinant core protein resulted in activation of TLR2-dependent signaling. In contrast, neither infectious virions nor enveloped HCV-like particles triggered TLR2 and TLR4 signaling. These findings suggest that monomeric HCV core protein but not intact infectious particles are sensed by of the polyprotein occurs by a combination of host and viral proteases. The HCV structural proteins comprise the putative nucleocapsid or core protein and the 2 envelope glycoproteins E1 and E2 [1] .
Toll-like receptors (TLRs) are transmembrane pathogen recognition receptors that activate the innate immune system. To date, 10 complete members of the TLR family are expressed in humans (TLRs 1-10). Most of them are predominantly expressed on the cell surface (TLRs 1, 2, 4-6 and 10) to sense extracellular pathogenassociated molecular patterns, such as lipoproteins (TLR2 ligand) and lipopolysaccharide (LPS, TLR4 ligand). In contrast, TLRs 3 and 7-9 are located in intracellular compartments. Recognition of pathogen-associated molecular patterns by TLRs induces the activation of genes important for an effective host defense. Stimulation of TLR signaling pathways by ligand-induced multimerization leads to the recruitment of several intracellular adaptor molecules and kinases, resulting in the activation of nuclear factor B (NF-B), cytokine secretion and expression of co-stimulatory molecules [2] .
It has been well documented that intracellular TLRs are involved in recognition of viral nucleotides and induction of antiviral interferon responses [reviewed in 2 ]. Cell surface expressed TLRs, such as TLR2 and TLR4, play an important role in human host defenses against viruses, such as herpes simplex virus, cytomegalovirus, respiratory syncytial virus and measles virus [3] .
HCV proteins have been shown to up-regulate TLR2 and TLR4 expression on Raji cells and peripheral blood mononuclear cells, thereby modulating their proinflammatory responses [4, 5] . Moreover, recent studies have provided evidence that the HCV core can activate TLR2 [6, 7] . The authors used recombinant monomeric C-terminal truncated core protein and full-length core protein fused to ␤-galactosidase to stimulate TLR2-expressing HEK cells and mouse macrophages. However, the significance of an interaction between recombinant HCV core protein and TLR2 for the induction of innate immune responses to viral infection is unknown. Studies on HCVhost interaction had been hampered for a long time by the lack of an efficient tissue culture model for HCV infection. Thus, alternative model systems, such as recombinant proteins, enveloped HCV-like particles [8, 9] and pseudotype particles [10] have been developed to study defined aspects of the HCV life cycle [for review see 11 ] . A major breakthrough for the study of HCV-host cell interaction was the recent establishment of an efficient cell culture system for HCV [12] [13] [14] . This model system now allows study of the interaction between authentic infectious viral particles and human target cells. To address the role of TLR2 and TLR4 for sensing assembled HCV particles and the impact of this interaction for HCV pathogenesis, we studied TLR2 and TLR4 activation by cell-culture-derived infectious virions (HCVcc) and serum-derived virions in comparison to purified recombinant HCV structural proteins and enveloped virus-like particles.
Materials and Methods

Reagents
Recombinant HCV core fused to ␤ -galactosidase, core aa 1-119 and core aa 2-192 were from Biodesign and Austral Biologicals, respectively. Alternatively, core aa 1-119 (genotype 1a) fused to a His-tag was expressed in E. coli strain BL21 (DE3) and purified as described [15] . This protein preparation was free of endotoxin as tested by the Limulus assay. Recombinant HCV E1 and E2 (genotype 1b) have been described [15, 16] . Mouse anti-core monoclonal antibody (mAb) has been described [8] . HCV-like particles were synthesized and purified from insect cells infected with recombinant baculoviruses containing the cDNA of the HCV structural proteins of HCV strain H77c (genotype 1a) as described [17] . HCV core protein within HCV-like particles was quantified as described [18] . Cells CHO fibroblast cell lines stably transfected with a reporter construct that encodes for CD25 under transcriptional control of the human E selectin (ELAM) promoter, hygromycin resistance, human CD14 plus human Flag-tagged TLR2 or TLR4 have been described elsewhere [19] [20] [21] [22] [23] . Upon stimulation with LPS, TNF ␣ or IL-1 ␤ , the ELAM promoter drives the expression of surface CD25 as a result of NF-B translocation. TLR2 and TLR4 transfected CHO cells were cultured in Ham's F12 medium (BioWhittaker) supplemented with 10% FBS (HyClone), 2 m M L -glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, 400 U/ml hygromycin B (Calbiochem) and 1 mg/ml G418 (Invitrogen). Human epithelial kidney (HEK) 293 cells (ATCC) stably transfected with human TLR2 (HEK/TLR2) or human TLR4-YFP and human MD-2 (HEK/TLR4) have been described previously [24] . HEK293 cells were maintained by serial passage in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% FBS, L -glutamine, ciprofloxacin and G418. Isolation and maintenance of primary human hepatocytes has been described [25] . Huh-7.5 cells have been previously described [26] . Cells were maintained in DMEM supplemented with 10% FBS (PAN-Biotech), 100 U/ml penicillin, 100 g/ml streptomycin and non-essential amino acids.
Generation of HCVcc and Infection of Huh7.5.
Plasmids encoding the full-length HCV JFH1 cDNA as well as the E1 and E2 deleted mutant JFH1/ ⌬ E1E2 have been described [12] . In vitro HCV RNA synthesis [27] and RNA transfection was carried out as described [14, 28] . Supernantants from HCV RNA transfected Huh7.5 cells were collected and concentrated as described [12] . For detection of HCV proteins in transfected cells, proteins were separated by SDS-PAGE, followed by immunoblot-ting with mouse anti-core mAb and sheep peroxidase-labeled anti-mouse polyclonal antibodies. 5 ! 10 4 naïve cells/well were seeded 24 h prior to infection experiments in 12-well tissue culture plates. Cells were infected for 3 h at 37 ° C with HCVcc and then incubated with complete medium for the indicated times. Cells were then washed with ice-cold PBS, total RNA extracted and HCV RNA quantitated using Versant HCV-RNA 3.0 Assay (bDNA; Bayer Corp. Diagnostic). Immunofluorescence was performed 48 h after infection using mouse anti-core mAb and goat Cy3-labeled anti-mouse polyclonal anitbodies (Jackson Immunoresearch). Nuclear staining was performed using DAPI (4,6-diamidino-2-phenylindole).
Analysis of NF-B-Dependent CD25 Cell Surface Expression on CHO 3E10, 3E10/TLR2 and 3E10/TLR4 Cells
4 cells/well were seeded 24 h prior to experiments in 24-well tissue culture plates. Cells were washed 3 times with PBS and then stimulated for 18 h with medium, LPS, peptidoglycan (PG), recombinant HCV proteins, HCV-like particles or HCVcc, detached from the plastic with trypsin/EDTA, and examined by flow cytometry (Facscalibur and CellQuest 3.11 software, Becton Dickinson) for the presence of surface CD25 as described [20] [21] [22] [23] .
Luciferase Reporter Assays for NF-B Activation
HEK293 cells that stably expressed human TLR2 or TLR4 as well as wild-type HEK cells were seeded into 96-well tissue culture plates at a density of 2 ! 10 4 cells/well. The following day, HEK293 cells were transiently transfected with a luciferase reporter gene using Fugene (Roche) according to the manufacturer's instructions. To assess NF-B activation, a reporter gene consisting of an E-selectin promoter driving a firefly luciferase gene (pELAM.luc) was used. Huh7.5 cells were seeded into 96-well tissue culture plates at a density of 2 ! 10 4 cells/well. The following day, cells were transfected with pELAM.luc or cotransfected with pELAM.luc and human TLR2 FLAG . Twenty-four hours after transfection, HEK293 and Huh7.5 cells were washed and then challenged for 18 h and 5 h, respectively, with medium, LPS, PG, recombinant HCV proteins, HCV-like particles or HCVcc at the indicated concentrations. Cells were then lysed and reporter gene activity was measured using a plate reader luminometer (Berthold Detection Systems).
RT-PCR for TLRs
RNA from primary hepatocytes and Huh7.5 hepatoma cells was extracted with TRI reagent (Sigma) and transcribed into cDNA with the Access Quick RT-PCR kit (Promega). The sequences of the employed primer pairs for PCR were 5 -AGGC-TGCATTCCCAAGACACT-3 and 5 -AGCCAGGCCCACAT-CATTTT-3 for TLR2 and 5 -TGCGGGTTCTACATCAAA-3 and 5 -CCATCCGAAATTATAAGAAAAGTC-3 for TLR4.
Results
Interaction of HCV with TLR2 and TLR4 on HCV Target Cells
It has been shown that HCV proteins may interact with TLR2 on monocytes/macrophages and trigger a proinflammatory immune reponse [6, 7] . In view of the potential role of TLRs in the recognition of HCV by human hepatocytes, we studied whether TLR2 and TLR4 are expressed both in primary human hepatocytes (the natural target cell for HCV infection) and the human hepatoma cell line Huh7.5 (a cell line susceptible to infection with recombinant cell culture-derived HCV). Using TLR2 and TLR4-specific RT-PCR we demonstrate that TLR2 and TLR4 mRNA can be easily detected in primary human hepatocytes and Huh7.5 cells ( fig. 1 ). These data suggest that TLR2 and TLR4 are expressed not only in antigen-presenting cells but also in primary human hepatocytes -the key target cells of HCV infection.
TLR Activation by HCV Structural Proteins
To study whether the interaction of the viral envelope, the viral nucleocapsid or enveloped particles with TLR2 and TLR4 results in TLR signaling, we used 2 well-established model systems allowing specific and reliable determination of the activation of TLR2-and/or TLR4-dependent signaling: stably transfected CHO cells expressing human TLR2 and/or TLR4 on their cell surface and a reporter gene allowing detecting ligand-induced TLR activation [23] as well as TLR2-or TLR4-transfected HEK293 cells [24] .
As shown in figure 2 a, the TLR2 ligand PG and recombinant C-terminally truncated core protein (0.1-10 g/ ml) activated TLR2 transfected CHO cells in a dose-dependent fashion, whereas heat inactivated core (10 g/ ml) had no effect ( fig. 2 a) . In contrast, enveloped HCVlike particles (containing 1-10 g/ml core protein) or recombinant envelope proteins E1 and E2 (10 g/ml) did not result in transcriptional activation of TLR2-transfected CHO cells ( fig. 2 a) . Similar results were obtained with HEK293 transfected with human TLR2 ( fig. 2 c) . As shown in figure 2 c, whereas recombinant C-terminally truncated core (aa 1-119) or full-length core (aa 2-192) protein fused to ␤-galactosidase resulted in TLR2 activation as demonstrated by induction of NF-B luciferase reporter gene expression, enveloped HCV-like particles containing comparable amounts of core protein did not induce TLR2 activation ( fig. 2 c) .
Next, we used TLR4 expressing cells to study whether enveloped HCV-like particles induce TLR4 signaling. Our results show that neither HCV core protein (10 g/ ml) nor HCV envelope proteins E1 and E2 (10 g/ml) trigger TLR4 activation in transfected CHO and HEK293 cells ( fig. 2 b, d) . Moreover, enveloped HCV-like particles were not able to stimulate TLR4 signaling ( fig. 2 b, d) .
Taken together, these results suggest that HCV core protein induces NF-B activation through interaction with TLR2, but not TLR4. In contrast, neither recombinant envelope glycoproteins nor enveloped HCV-like particles containing an intact nucleocapsid [29] induced TLR2-dependent signaling pathways.
TLR Activation by Cell Culture-Derived Infectious HCV
To determine the impact of these findings for the interaction of authentic infectious HCV with TLRs, we produced recombinant infectious virions (HCVcc) derived from the HCV JFH1 strain in human Huh7.5 hepatoma cells ( fig. 3 a-c) using the recently established tissue culture system for HCV infection [12] [13] [14] . The infectivity of produced virions was confirmed by detection of HCV RNA and HCV proteins in infected Huh7.5 cells using HCV-specific RT-PCR and immunofluorescence ( fig. 3 b,  c) . We then added HCVcc (tested for infectivity as described in fig. 3 b, c) to stably transfected CHO and HEK293 reporter cells in various concentrations ( fig. 3 d) .
Our results show that infectious HCVcc, at concentrations able to infect human hepatoma Huh7.5 cells ( fig. 3 b,  c) , did not significantly activate TLR2 or TLR4 depending signaling pathways in TLR2 and TLR4 expressing CHO and HEK293 cells when compared to non-infectious supernatants from envelope protein-deficient JFH1/ ⌬ E1E2 RNA transfected Huh7.5 cells ( fig. 3 d) . HCV RNA levels (10 5 -10 7 GE/ml) in HCVcc preparations were in a similar range as the typical viral load in patients with chronic HCV infection. HCVcc core concentrations in HCVcc preparations (10 5 -10 7 GE/ml) typically range in between 150 pg/ml and 33 ng/ml core protein [Pietschmann T., pers. commun.; 12, 30 ] , which is in a similar range as core HCV concentrations measured in serum of HCV-infected patients (ranging typically from 20 pg/ml to 5 ng/ml) [31, 32] .
To confirm the results obtained with recombinant cell culture-derived HCVcc, we incubated reporter cell lines with serum-derived HCV from chronically infected pa- tients. Similar to findings with cell culture-derived HCVcc, we neither observed a TLR2 nor TLR4 activation following incubation of reporter cell lines with native HCV (data not shown). These data demonstrate that in contrast to efficient TLR2 sensing of core protein preparations, neither recombinant nor serum-derived infectious virions are efficiently sensed by TLR2. Taken together, these results suggest that monomeric core protein, but not core as part of authentic infectious virions induces TLR2 signaling.
Discussion
Our data indicate that HCV core protein is sensed by TLR2. In contrast, neither recombinant nor serum-derived infectious HCV resulted in efficient activation of TLR2 signaling. Although target cell lines including human dendritic cells [18] and hepatocytes express TLR2 at significant levels ( fig. 1 ) , our results indicate that HCV core sensing by TLR2 appears to be absent in enveloped viral particles. 7 GE/ml (JFH1 or JFH1/ ⌬ E1E2) and subsequently incubated for 48 h at 37 ° C with Huh7.5 medium. HCV core protein expression was detected using an anti-core monoclonal antibody and a Cy3-conjugated anti-mouse IgG antibody (red fluorescence). Nuclear staining was performed using DAPI (4,6-diamidino-2-phenylindole; blue fluorescence). d TLR-activation by HCVcc -as produced and characterized in a-c -in transfected CHO and HEK293 cells. CHO cells were incubated with HCVcc at 10 7 GE/ml and HEK293 with HCVcc at 10 5 , 10 6 and 10 7 GE/ml (corresponding to approximately 150 pg/ml to 33 ng/ml core protein) for 18 h at 37 ° C. Incubation of cells with complete medium (M), PG (10 g/ml), LPS (1 g/ml) or recombinant core protein (10 g/ml) served as negative and positive controls, respectively. TLR-activation was determined as described in legend of figure 2. n.d. = Not determined.
Since recombinant core proteins were able to induce TLR2 activation at concentrations as low as 0.1 g/ml ( fig. 2 b) and enveloped HCV-like particles did not activate TLR2 signaling at high HCV-like particle core concentrations (up to 10 g/ml), it is unlikely that the lack of HCV-like particle-induced TLR2 activation was due to a dose-dependent effect. Moreover, as HCV RNA (10 5 -10 7 GE/ml) and core (approx. 150 pg/ml-33 ng/ml) levels in supernatants from Huh7.5 cells [12, 30] were in the same range as HCV RNA (ranging typically from 10 5 to 10 7 GE/ml) and core (ranging typically from 20 pg/ml to 5 ng/ml) levels in plasma of HCV-infected patients [31] [32] [33] [34] , it is unlikely that the quantity of infectious virions was not sufficient to detect physiological relevant HCV TLR2 activation.
HCV is a virus prone to persistence that has developed different strategies to evade the host's innate and adaptive immune responses. HCV has been shown to interfere with innate antiviral defenses through multiple mechanisms; for example, core protein induces expression of SOCS-3 which suppresses Jak-STAT signaling, and NS3/4A protease is an antagonist of IRF-3 activation and interferon-␤ expression by blocking RIG-I and TLR3 signaling [reviewed in 35, 36 ] . The fact that in contrast to purified core, enveloped HCV-like particles and infectious virions were less efficient in activating TLR2 suggests that multimeric core protein as part of an enveloped nucleocapsid may escape the host's innate immune responses. Our results indicate that 2 mechanisms may explain this escape: (1) in intact viral particles, the core protein may adopt a conformation that might not be recognized by TLR2; (2) the envelope glycoproteins in infectious virions impair HCV core-sensing by TLR2.
The first hypothesis -conformation-dependent sensing of core protein -is supported by the finding that denaturation of monomeric core protein by heat treatment completely abolished TLR2 sensing ( fig. 2 ) . Furthermore, this hypothesis is supported by the fact that preparations of partially purified HCV-like particles have been shown to contain de-enveloped core-containing structures [29] and still are not able to induce TLR signaling ( fig. 2 ). In addition, supernatants from envelope protein-deficient JFH1/ ⌬ E1E2 RNA transfected Huh7.5 cells that also contain core protein [as shown in 12 ] but not infectious enveloped particles ( fig. 4 ) were inefficient in activating TLR signaling. Taken together, these findings suggest that multimeric core protein as part of a nucleocapsid is less efficient in TLR2 activation than monomeric core protein.
The second hypothesis -impairment of core sensing by the HCV envelope -is supported by the finding that recombinant envelope glycoproteins and enveloped recombinant and patient-derived HCV were not able to induce TLR2 activation ( fig. 2 ). This hypothesis is further supported by the finding that TLR2-and/or TLR4-transfected CHO cells did not bind recombinant envelope proteins or enveloped HCV-like particles (data not shown) and that interaction of enveloped HCV-like particles with dendritic cells is independent of cell surface TLR2 [18] .
What is the impact of these findings for sensing of HCV core protein by TLR2 in vivo? HCV entry into host cells has been demonstrated to be a complex process involving several binding and entry factors ultimately leading to decapsidation of the virus in endosomal compartments and release of viral RNA into the cytoplasm. Since monomeric core protein, but not core as part of a nucleocapsid or subviral particle, interacts with TLR2, it is conceivable that HCV particles are not sensed by cell surface-expressed TLR2 during binding and early entry steps. In vivo, TLR2 sensing and activation will most likely be triggered by core protein that results from degraded nucleocapsids or unassembled core protein released from disintegrated infected hepatocytes at distinct sites of the infected host. Since recent studies demonstrate evidence for intracellular expression of TLRs [37] , it is also conceivable that core-TLR2 interaction and activation may occur following viral uncoating or production of monomeric protein in an intracellular compartment.
In summary, our data demonstrate that only monomeric core protein -and not infectious viral particlesare sensed by TLR2. Impairment of core-TLR interaction in infectious particles may contribute to escape from innate antiviral immune responses and facilitate persistence of HCV infection.
